Skip to Content

RP 200 (Fenofibrate (Micronized) 200 mg)

Pill with imprint RP 200 is Orange, Capsule-shape and has been identified as Fenofibrate (Micronized) 200 mg. It is supplied by Rhodes Pharmaceuticals.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RP 200

Fenofibrate (micronized) 200 mg RP 200

Fenofibrate (Micronized)

Imprint
RP 200
Strength
200 mg
Color
Orange
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Rhodes Pharmaceuticals
Manufacturer
Teva Canada Limited
National Drug Code (NDC)
42858-0200
Inactive Ingredients
croscarmellose sodium, lactose monohydrate, magnesium stearate, povidone k25, corn starch, sodium lauryl sulfate, magnesium silicate, FD&C Red No. 40, D&C Red No. 28, ferric oxide yellow, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "RP 200"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.